MedicalSentry

Health Research Company

Concerta

generic name is Methylphenidate hydrochloride

Why is this drug subscribed ?

Methylphenidate is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in adults and children. Methylphenidate (Ritalin, Ritalin SR, Methylin, Methylin ER) is also used to treat narcolepsy (a sleep disorder that causes excessive daytime sleepiness and sudden attacks of sleep). Methylphenidate is in a class of medications called central nervous system (CNS) stimulants. It works by changing the amounts of certain natural substances in the brain.

Active Substance: METHYLPHENIDATE HYDROCHLORIDE

Concerta Available Drugs :

Concerta ndc# 54868-4957

by Physicians Total Care, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 27 mg/1

started marketing at 13/11/2003 .

Concerta ndc# 54868-4759

by Physicians Total Care, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 36 mg/1

started marketing at 20/03/2003 .

Concerta ndc# 54868-4789

by Physicians Total Care, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 54 mg/1

started marketing at 08/05/2003 .

Concerta ndc# 54868-4489

by Physicians Total Care, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 18 mg/1

started marketing at 21/03/2003 .

CONCERTA ndc# 50458-585

by Ortho-McNeil-Janssen Pharmaceuticals, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 18 mg/1

started marketing at 01/08/2000 .

CONCERTA ndc# 50458-587

by Ortho-McNeil-Janssen Pharmaceuticals, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 54 mg/1

started marketing at 01/08/2000 .

CONCERTA ndc# 50458-586

by Ortho-McNeil-Janssen Pharmaceuticals, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 36 mg/1

started marketing at 01/08/2000 .

CONCERTA ndc# 50458-588

by Ortho-McNeil-Janssen Pharmaceuticals, Inc.

ORAL TABLET, EXTENDED RELEASE with active strength of 27 mg/1

started marketing at 01/08/2000 .

Concerta Search Trends:

News :

Social Buzz

comments powered by Disqus